Use of emicizumab in Venezuelan haemophilia A patients: Preliminary report

被引：0
|
作者：
Boadas, Apsara [1 ]
Ruiz-Saez, Arlette [1 ]
Aponte, Laura [2 ]
Echenagucia, Marion [3 ]
Lugo, Ines [4 ]
Tersek, Yraida [5 ]
机构：
[1] Dept Invest & Docencia, Caracas, Venezuela
[2] Natl Hemophilia Ctr Venezuela Banco Municipal San, Caracas, Venezuela
[3] Lab Hemostasia Banco Municipal Sangre DC, Caracas, Venezuela
[4] Hosp Rafael Tobias, Barcelona, Venezuela
[5] Hosp Cent San Felipe, San Felipe, Estado Yaracuy, Venezuela
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
emicizumab; haemophilia A patients; prophylaxis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-68 (116
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [21] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    HAEMOPHILIA, 2021, 27 : 116 - 116
  • [22] The effect of emicizumab regimen on haemophilia outcomes
    Ragni, Margaret V.
    LANCET HAEMATOLOGY, 2019, 6 (06): : E286 - E287
  • [23] Emicizumab for acquired haemophilia A: A case series
    Engelen, Matthias M.
    Vandesande, Johan
    De Bent, Johan
    Van Laer, Christine
    Labarque, Veerle
    Jacquemin, Marc
    Peerlinck, Kathelijne
    Hermans, Cedric
    Verhamme, Peter
    Vanassche, Thomas
    HAEMOPHILIA, 2023, 29 (04) : 1049 - 1055
  • [24] Emicizumab for the treatment of haemophilia A: a narrative review
    Franchini, Massimo
    Marano, Giuseppe
    Pati, Ilaria
    Candura, Fabio
    Profili, Samantha
    Veropalumbo, Eva
    Masiello, Francesca
    Catalano, Liviana
    Piccinini, Vanessa
    Vaglio, Stefania
    Pupella, Simonetta
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2019, 17 (03) : 223 - 228
  • [25] LOW IMMUNOGENICITY OF EMICIZUMAB IN PERSONS WITH HAEMOPHILIA A
    Schmitt, C.
    Emrich, T.
    Asikanius, E.
    Chebon, S.
    Fernandez, E.
    Petry, C.
    Yoneyama, K.
    Kiialainen, A.
    Kuebler, P.
    Niggli, M.
    Paz-Priel, I.
    Chang, T.
    HAEMOPHILIA, 2021, 27 : 96 - 97
  • [26] Approach strategy for adherence to emicizumab treatment in patients with severe Haemophilia A in Uruguay
    Echeverria, Silvina
    Gomez, Florencia
    Boggia, Beatriz
    Lemos, Felipe
    HAEMOPHILIA, 2023, 29 : 19 - 20
  • [27] Safety, efficacy and laboratory profile of reduced emicizumab dosing in haemophilia A patients
    El Beayni, N.
    Szanto, T.
    Lehtinen, A. E.
    Lassila, R.
    HAEMOPHILIA, 2024, 30 : 81 - 81
  • [28] Emicizumab for non-severe haemophilia A
    Makris, Michael
    LANCET HAEMATOLOGY, 2023, 10 (03): : E158 - E159
  • [29] Low immunogenicity of emicizumab in persons with haemophilia A
    Schmitt, Christophe
    Emrich, Thomas
    Chebon, Sammy
    Fernandez, Elena
    Petry, Claire
    Yoneyama, Koichiro
    Kiialainen, Anna
    Howard, Monet
    Niggli, Markus
    Paz-Priel, Ido
    Chang, Tiffany
    HAEMOPHILIA, 2021, 27 (06) : 984 - 992
  • [30] Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors
    Lockhart, Marguerite
    Tardy-Poncet, Brigitte
    Montmartin, Aurelie
    Noyel, Pauline
    Thouvenin, Sandrine
    Berger, Claire
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
12345